Latest News

Filters close
Released: 27-Jul-2021 12:50 PM EDT
Memorial Sloan Kettering Cancer Center Ranked #1 Nationally for Ear, Nose, and Throat Care by U.S. News & World Report
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the number one center for ear, nose, and throat care by U.S. News & World Report in its annual Best Hospitals listing. MSK has been consistently ranked among the top two cancer centers in the country for over 30 years.

Released: 27-Jul-2021 12:45 PM EDT
Memorial Sloan Kettering Cancer Center Recognized as One of the Best Hospitals for Cancer Care by U.S. News & World Report for the 32nd Year in a Row; Ranked #1 Nationally for Ear, Nose, and Throat Care
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the number two hospital for cancer care in the nation by U.S. News & World Report in its annual Best Hospitals listing. Since these prestigious rankings were established more than 30 years ago, MSK has consistently ranked among the top two cancer hospitals in the country.

3-Jun-2021 1:00 PM EDT
ASCO 2021: PSMA-Targeted Radioligand Therapy Improves Survival in Metastatic Prostate Cancer
Memorial Sloan Kettering Cancer Center

New data from researchers at Memorial Sloan Kettering Cancer Center (MSK) featured in the 2021 ASCO Annual Meeting press program highlights a promising new treatment option for individuals previously treated for metastatic castration-resistant prostate cancer (mCRPC).

Newswise: Immunotherapy after Bladder Cancer Surgery May Reduce Recurrence, Study Shows
Released: 3-Jun-2021 4:30 PM EDT
Immunotherapy after Bladder Cancer Surgery May Reduce Recurrence, Study Shows
Memorial Sloan Kettering Cancer Center

New research from Memorial Sloan Kettering Cancer Center (MSK) medical oncologist Dean Bajorin, MD, and colleagues found that patients who received nivolumab (Opdivo®) after bladder cancer surgery reduced their overall risk for high-grade bladder cancer recurrence. This research was published today in the New England Journal of Medicine.

Newswise:Video Embedded msk-to-recognize-2021-gerstner-sloan-kettering-gsk-graduates-during-virtual-commencement-on-may-19-2021
VIDEO
Released: 19-May-2021 10:00 AM EDT
MSK to Recognize 2021 Gerstner Sloan Kettering (GSK) Graduates During Virtual Commencement on May 19, 2021
Memorial Sloan Kettering Cancer Center

During a virtual commencement ceremony on Wednesday, May 19, 2021, at 3:00 PM ET, Memorial Sloan Kettering Cancer Center (MSK) will recognize seven Gerstner Sloan Kettering (GSK) 2021 graduates and honor Joan Argetsinger Steitz, PhD, Sterling Professor of Molecular Biophysics and Biochemistry at Yale School of Medicine and a Howard Hughes Medical Institute Investigator, with the 2021 Honorary Degree and the Memorial Sloan Kettering Medal for Outstanding Contributions to Biomedical Research.

Released: 13-May-2021 11:40 AM EDT
Memorial Sloan Kettering Announces New Initiative to Focus on Lung Cancer Research
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) today announced a $20 million gift from the Ge Li & Ning Zhao Family Foundation to support lung cancer research and the development of new therapies to treat this disease.

Released: 12-May-2021 8:30 PM EDT
Recognizing Outstanding Service in Nursing at MSK: Second Annual Robbins Family Awards
Memorial Sloan Kettering Cancer Center

During a virtual awards ceremony today, Memorial Sloan Kettering Cancer Center (MSK) and the Robbins Family Foundation recognized eight distinguished MSK staff members and one team for their exemplary service. Each member was honored with the 2021 Robbins Family Award for Nursing Excellence. The virtual awards ceremony took place today, Monday, May 12, at 8:30 AM ET, to commemorate National Nurses Week (May 6–12).

Released: 12-May-2021 8:05 AM EDT
Recognizing Outstanding Service in Nursing at MSK: Second Annual Robbins Family Awards
Memorial Sloan Kettering Cancer Center

During a virtual awards ceremony today, Memorial Sloan Kettering Cancer Center (MSK) and the Robbins Family Foundation recognized eight distinguished MSK staff members and one team for their exemplary service. Each member was honored with the 2021 Robbins Family Award for Nursing Excellence. The virtual awards ceremony took place today, Monday, May 12, at 8:30 AM ET, to commemorate National Nurses Week (May 6–12).

Released: 10-Apr-2021 8:30 AM EDT
MSK Medical Oncologist Matthew Matasar Featured in the 2021 AACR Annual Meeting Week 1 Press Program
Memorial Sloan Kettering Cancer Center

Research Presented Found that Copanlisib-Rituximab Combination Reduced Lymphoma Progression or Death by Nearly Half in CHRONOS-3 Trial

Released: 19-Mar-2021 1:05 PM EDT
Memorial Sloan Kettering Announces New Awards and Appointments
Memorial Sloan Kettering Cancer Center

New York City's Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments for March 2021.

Newswise: Sloan Kettering Institute Researchers Named 2021 Kravis Women in Science Endeavor Fellowship Grant Recipients
Released: 10-Mar-2021 10:15 AM EST
Sloan Kettering Institute Researchers Named 2021 Kravis Women in Science Endeavor Fellowship Grant Recipients
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) announced that Sloan Kettering Institute (SKI) researchers Regina Bou Puerto and Mijin Kim, PhD, have been named 2021 Marie-Josée Kravis Women in Science Endeavor (Kravis WiSE) fellowship grant recipients. The Kravis WiSE initiative, created in 2020, provides sustained funding for scientific trainees as well as mentoring and significant professional development for women pursuing careers in biomedical research at MSK. The Kravis WiSE Symposium is held every year during Women’s History Month in March. This event hosts scientific leaders from MSK and other institutions.

Released: 19-Feb-2021 8:05 PM EST
Memorial Sloan Kettering Announces New Awards and Appointments
Memorial Sloan Kettering Cancer Center

New York City's Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments for February 2021.

Newswise: Memorial Sloan Kettering Announces Newly Endowed Chair and Fellowships for Health Equity and Diversity
8-Feb-2021 1:00 PM EST
Memorial Sloan Kettering Announces Newly Endowed Chair and Fellowships for Health Equity and Diversity
Memorial Sloan Kettering Cancer Center

The new positions reflect MSK’s commitment to expanding patient access to cancer care and supporting ongoing research aimed at reducing cancer disparities that stem from racial, ethnic, cultural, or socioeconomic barriers.

Newswise: Memorial Sloan Kettering and the Cancer Community Urge Americans to Resume Cancer Screenings and Treatment
Released: 28-Jan-2021 8:35 AM EST
Memorial Sloan Kettering and the Cancer Community Urge Americans to Resume Cancer Screenings and Treatment
Memorial Sloan Kettering Cancer Center

Early detection helps improve patient outcomes, but data shows that many cancers are going undiagnosed or untreated because of COVID-19.

Released: 25-Jan-2021 9:50 AM EST
Memorial Sloan Kettering Awards & Appointments
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

Released: 16-Dec-2020 2:15 PM EST
Memorial Sloan Kettering Awards & Appointments
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) announces recent awards and appointments.

Newswise: Memorial Sloan Kettering Department of Nursing Achieves Magnet® Recognition
Released: 25-Nov-2020 12:10 PM EST
Memorial Sloan Kettering Department of Nursing Achieves Magnet® Recognition
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering attained Magnet recognition for the second time, a testament to our continued dedication to high-quality nursing practice.

Released: 18-Nov-2020 2:55 PM EST
Memorial Sloan Kettering Announces New Awards and Appointments
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments:

Released: 29-Oct-2020 3:15 PM EDT
Four MSK Researchers Receive 2020 Outstanding Investigator Award from the National Cancer Institute
Memorial Sloan Kettering Cancer Center

Four MSK researchers out of 15 winners nationwide were named recipients of the prestigious award. They will each receive a grant of up to $600,000 per year for seven years to support their research in cancer.

Released: 29-Oct-2020 3:15 PM EDT
Ingo Mellinghoff Named Chair of MSK’s Department of Neurology
Memorial Sloan Kettering Cancer Center

Neuro-oncologist and renowned physician-scientist Ingo Mellinghoff will lead MSK’s distinguished Department of Neurology after previously serving as Acting Co-Chair.

Released: 16-Oct-2020 11:45 AM EDT
Memorial Sloan Kettering Awards and Appointments
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

Released: 6-Oct-2020 12:40 PM EDT
Computational Biologist Thomas Norman of Sloan Kettering Institute Honored with Distinguished NIH Director’s New Innovator Award
Memorial Sloan Kettering Cancer Center

Computational biologist Thomas Norman, PhD, of Memorial Sloan Kettering’s (MSK) Sloan Kettering Institute (SKI) has been named one of 53 recipients of the prestigious 2020 National Institutes of Health (NIH) Director’s New Innovator Award. As part of the award, Dr. Norman will receive $1.5 million in direct costs upfront in the first year of a five-year award.

Released: 17-Aug-2020 3:05 PM EDT
Memorial Sloan Kettering Awards and Appointments
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

Released: 28-Jul-2020 8:00 AM EDT
Memorial Sloan Kettering Named One of the Best Hospitals for Cancer Care by U.S. News & World Report for the 31st Year in a Row
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the number two hospital for cancer care in the nation by U.S. News & World Report in its annual Best Hospitals listing. Since U.S. News & World Report established the prestigious rankings more than 30 years ago, MSK has earned either the first or second spot for best cancer care in the country each year.

Released: 16-Jul-2020 12:10 PM EDT
Memorial Sloan Kettering Awards and Appointments
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

Released: 24-Jun-2020 2:55 PM EDT
MSK Researchers Find that Common Cancer Treatments Don’t Worsen Coronavirus Infection
Memorial Sloan Kettering Cancer Center

A team of researchers at Memorial Sloan Kettering Cancer Center (MSK) reported on the epidemiology of COVID-19 illness experienced at an NCI-designated cancer center during the height of pandemic in New York City.

Released: 23-Jun-2020 10:15 AM EDT
MSK Physician-Scientists Recognized with Top Honors by AACR, ASCO, and ASH Organizations
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and honors to our staff, given by the American Association for Cancer Research (AACR), the American Society of Clinical Oncology (ASCO), and the American Society of Hematology (ASH) organizations.

Released: 18-Jun-2020 10:05 AM EDT
MSK’s Visible Ink Writing Program Presents “On Cancer and Coronavirus,” Performed by Stars of Broadway, Film and TV
Memorial Sloan Kettering Cancer Center

On Thursday, June 18, at 6:00 p.m. E.T. with an encore at 9:00 p.m., Memorial Sloan Kettering Cancer Center (MSK) will stream a special performance on visibleink.vimeo.mskcc.org, highlighting poignant and humorous perspectives On Cancer and Coronavirus, featuring works from its writing program, Visible Ink. This will be the 12th annual performance of stories written by MSK patients, and the first presented virtually. Visible Ink has always worked with many participants remotely, so it was well positioned to continue to connect MSK patients with experienced writers to support their written expression.

Released: 15-Jun-2020 3:35 PM EDT
Memorial Sloan Kettering Awards & Appointments
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

Newswise: Memorial Sloan Kettering – Hackensack Meridian Health Partnership Announces Funding for Inaugural Immunology Research Collaboration Projects
Released: 8-Jun-2020 2:10 PM EDT
Memorial Sloan Kettering – Hackensack Meridian Health Partnership Announces Funding for Inaugural Immunology Research Collaboration Projects
Memorial Sloan Kettering Cancer Center

The Memorial Sloan Kettering – Hackensack Meridian Health Partnership has formed an Immunology Research Collaboration, through which researchers can apply for funding to support innovative investigations to explore the power of the immune system and ways it may be harnessed to fight cancer. Three researchers' projects were selected in 2020 for funding support.

Newswise: MSK: Cancer Isn’t Sheltering in Place
Released: 28-May-2020 12:10 PM EDT
MSK: Cancer Isn’t Sheltering in Place
Memorial Sloan Kettering Cancer Center

As the height of the COVID-19 outbreak in New York City and the Tri-State area begins to subside, Memorial Sloan Kettering Cancer Center oncologists are urging patients to schedule cancer screenings and treatments now – as the long-term toll of missed diagnoses and delayed treatments could be devastating for patients and their loved ones across the region and the country.

13-May-2020 3:10 PM EDT
ASCO 2020: First National-Scale Study on the Impact of Medicaid Expansion on Cancer Mortality Rates Highlighted in Press Program
Memorial Sloan Kettering Cancer Center

New data from researchers at Memorial Sloan Kettering Cancer Center (MSK) revealed the effects of Medicaid expansion on cancer death rates on a national scale. The landmark study found that states that adopted Medicaid expansion following the passage of the Affordable Care Act (ACA) in 2010 saw greater decreases in cancer mortality rates than states that did not. The findings were presented as part of the press program for this year’s virtual annual meeting of the American Society of Clinical Oncology (ASCO).

Newswise: MSK Kids Study: Children with Cancer are Not at a Higher Risk for COVID-19 Infection or Morbidity
Released: 13-May-2020 11:30 AM EDT
MSK Kids Study: Children with Cancer are Not at a Higher Risk for COVID-19 Infection or Morbidity
Memorial Sloan Kettering Cancer Center

Researches from MSK Kids at Memorial Sloan Kettering Cancer Center (MSK) found that children with cancer are not at a higher risk of being affected by COVID-19.

Released: 11-May-2020 3:10 PM EDT
Robbins Family Awards Honor Exemplary Service In Nursing at Memorial Sloan Kettering
Memorial Sloan Kettering Cancer Center

As we celebrate National Nurses Week, Memorial Sloan Kettering Cancer Center (MSK) and The Robbins Family Foundation recognize seven distinguished nursing staff members for their exemplary service. Each member of this select group is being honored with the inaugural 2020 Robbins Family Award for Nursing Excellence.

Released: 8-May-2020 11:10 AM EDT
Memorial Sloan Kettering Awards & Appointments
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

Newswise: Two Memorial Sloan Kettering Scientists Elected to Esteemed National Academy of Sciences
Released: 29-Apr-2020 11:10 AM EDT
Two Memorial Sloan Kettering Scientists Elected to Esteemed National Academy of Sciences
Memorial Sloan Kettering Cancer Center

Two researchers at Memorial Sloan Kettering Cancer Center’s (MSK) Sloan Kettering Institute (SKI) have been elected to the National Academy of Sciences (NAS). Scott Keeney, PhD, a molecular biologist, and Christopher Lima, PhD, a structural biologist, join more than a dozen MSK investigators who are already NAS members. SKI is the research enterprise of MSK, the world’s oldest and largest private cancer center. Members are elected in recognition of their distinguished and continuing achievements in original research. Membership is one of the highest honors bestowed upon scientists worldwide.

Released: 27-Feb-2020 1:15 PM EST
Memorial Sloan Kettering Awards & Appointments
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

Released: 26-Feb-2020 10:25 AM EST
The Tri-Institutional Therapeutics Discovery Institute, Inc. Renews Partnerships with Takeda and Bridge Medicines, LLC
Memorial Sloan Kettering Cancer Center

To date, work done within the Tri-I TDI has resulted in the launch of two New York City–based companies and the licensing of six therapeutic discovery programs.

Newswise: Memorial Sloan Kettering Appoints Roxanne Taylor as Chief Marketing and Communications Officer
Released: 14-Jan-2020 11:00 AM EST
Memorial Sloan Kettering Appoints Roxanne Taylor as Chief Marketing and Communications Officer
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center has appointed Roxanne Taylor as Chief Marketing and Communications Officer, effective February 3. In this role, Ms. Taylor will be responsible for shaping and enhancing the MSK brand and will be accountable for building the long-term equity of the brand with all stakeholders.

Newswise: A New Era of Care: The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center to Open in January 2020
Released: 10-Dec-2019 3:55 PM EST
A New Era of Care: The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center to Open in January 2020
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) today celebrated the opening of a $1.5 billion state-of-the-art cancer treatment facility with government officials, members of the Boards of Overseers and Managers, and staff. Opening for patient care next month, the 750,000-square-foot building is the institution’s — and the city’s — largest freestanding cancer care facility. The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center is a healing community dedicated to patient-centered care, made possible by a landmark donation and a pioneering vision that signifies a new era of cancer care.

Newswise: Claus Torp Jensen Has Been Appointed First Chief Digital Officer and Head of Technology for Memorial Sloan Kettering Cancer Center
Released: 14-Oct-2019 10:00 AM EDT
Claus Torp Jensen Has Been Appointed First Chief Digital Officer and Head of Technology for Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) today announced that Claus Torp Jensen, PhD, has joined the institution as its first Chief Digital Officer and Head of Technology. His recruitment follows an expansive national search to identify a leader with the vision and experience to lead MSK’s digital transformation.

Released: 8-Aug-2019 9:05 AM EDT
New Study Examines Wilms’ Tumor Relapse and May Give Clues to about Which Other Childhood Cancers Could Relapse
Memorial Sloan Kettering Cancer Center

Today, researchers from MSK Kids at Memorial Sloan Kettering Cancer Center (MSK) published results that examine elevated levels of a protein called prohibitin in the urine and tumors of children with Wilms’ tumors. Their findings could help doctors identify children who are at risk for disease recurrence and precisely tailor treatment to overcome drug resistance.

Released: 30-Jul-2019 10:05 AM EDT
Memorial Sloan Kettering Among the Top “Best Hospitals” for Cancer Care and Ranked First in Gynecology by U.S News & World Report
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) has been ranked as the number two hospital for cancer care in the nation, according to U.S. News & World Report in its annual listing of Best Hospitals. Since the inception of the rankings 30 years ago, MSK has held either the first or second spot each year for cancer care. In addition to its ranking for overall cancer care, MSK was ranked #1 in Gynecology.

Released: 18-Jul-2019 11:05 AM EDT
Cracking a Code: Landmark Prospective Study Helps Researchers Better Understand Which MGUS Patients Will Progress to a Multiple Myeloma Diagnosis
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) researchers published new results that found that individuals with low-risk or intermediate-risk myeloma precursor disease known as monoclonal gammopathy of undetermined significance (MGUS) can convert to high-risk MGUS and progress to multiple myeloma within a five-year window. This research clinically supports recommendations for annual blood tests for all individuals diagnosed with MGUS along with re-assessments of a patient’s clinical-risk status.

Released: 21-Jun-2019 3:00 PM EDT
MSK-ACCESS Receives New York State Approval for New Molecular Assay
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) announced that the New York State Department of Health has issued an approval for a new molecular assay called Analysis of Circulating cfDNA to Evaluate Somatic Status (MSK-ACCESS).

Released: 1-Apr-2019 4:05 PM EDT
Following Milestone FDA Approval, MSK Researchers Address Resistance to Larotrectinib through Next-Generation TRK-Targeted Therapeutic
Memorial Sloan Kettering Cancer Center

LOXO-195, a next-generation TRK inhibitor also known as BAY 2731954, has shown signs of clinical activity in individuals with NTRK gene fusion-positive solid tumors that have become resistant to first-generation TRK inhibitors. Results from a phase I clinical trial and a US Food and Drug Administration expanded access program were presented by David Hyman, MD, the Chief of the Early Drug Development Service at Memorial Sloan Kettering Cancer Center (MSK), at the American Association for Cancer Research (AACR) Annual Meeting 2019. This research is featured in the meeting’s press program, and findings are being presented in the “Next Generation of Clinical Trials in Molecularly Driven Therapy” minisymposium.

Released: 29-Jan-2019 12:05 PM EST
MSK Researchers Identify a New Method to “Genetically Cloak” Cancer-Fighting Immune Cells
Memorial Sloan Kettering Cancer Center

During cancer immunotherapy, immune cells often undergo a form of cellular suicide, termed apoptosis, which can limit the therapy’s effectiveness.

Released: 3-Dec-2018 10:05 AM EST
New Study Reveals Gut Microbes May Help Protect People Having a Bone Marrow Transplant
Memorial Sloan Kettering Cancer Center

Researchers at Memorial Sloan Kettering Cancer Center (MSK) reported results from a new study that looks at the likelihood of complications for people undergoing bone marrow transplants (BMTs). The observational study found that people with lower gut microbiota diversity before having a transplant appear to be at higher risk for developing complications. These findings further support evidence that the connection between microbiota and outcomes starts before people begin the transplantation process. These findings were presented as part of the 2018 annual meeting of the American Society of Hematology (ASH) press program.

Released: 29-Nov-2018 3:05 PM EST
Memorial Sloan Kettering Researchers at ASH Annual Meeting
Memorial Sloan Kettering Cancer Center

MSK experts in CAR-T therapy, immunotherapy, leukemia, lymphoma, blood and marrow stem cell transplantation, and more, are also available to comment on meeting news.

Released: 8-Oct-2018 3:55 PM EDT
Fecal Transplants Proven to Restore Health-Promoting Bacteria
Memorial Sloan Kettering Cancer Center

A randomized clinical trial at Memorial Sloan Kettering Cancer Center (MSK) has shown that fecal microbiota transplants (FMTs)


Showing results

150 of 366

close
0.57947